Dishman Carbogen Amcis Hits 52-Week High, Outperforms Sensex Despite Recent Dip

Dishman Carbogen Amcis, a smallcap pharmaceutical company, has recently hit a 52-week high on February 8th, 2024. The stock price reached Rs. 217.9, which is a significant increase from its previous levels. However, according to MarketsMOJO, the stock call for Dishman Carbogen Amcis is 'Sell'.

The stock's performance today has underperformed the sector by -3.04%, and there has been a trend reversal as the stock has fallen after two consecutive days of gains. The day's low for the stock was Rs. 208.5, which is a decrease of -2.71%.

Despite the recent dip, Dishman Carbogen Amcis is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates that the stock has been performing well in the market.

In terms of overall performance, Dishman Carbogen Amcis has outperformed the Sensex by a significant margin. In the past year, the stock has seen a growth of 150.00%, while the Sensex has only grown by 19.15%. This shows the strong performance of the company in the pharmaceutical industry.

As a smallcap company, Dishman Carbogen Amcis has shown promising growth and potential in the market. However, according to MarketsMOJO, the current stock call is 'Sell', so investors should carefully consider their options before making any investment decisions.